APO Research
Talk to an analyst

APO RESEARCH · REPORT

Fluorescence-Guided Surgery Systems

Fluorescence guided surgery (FGS), (also called 'Fluorescence image-guided surgery', or in the specific case of tumor resection, 'fluorescence guided resection') is a medical imaging technique used to detect fluorescently labelled structures during surgery. Similarly, to standard image-guided surgery, FGS has the purpose of guiding the surgical procedure and providing the surgeon of real time visualization of the operating field. When compared to other medical imaging modalities, FGS is cheaper and superior in terms of resolution and number of molecules detectable.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Fluorescence guided surgery (FGS), (also called 'Fluorescence image-guided surgery', or in the specific case of tumor resection, 'fluorescence guided resection') is a medical imaging technique used to detect fluorescently labelled structures during surgery. Similarly, to standard image-guided surgery, FGS has the purpose of guiding the surgical procedure and providing the surgeon of real time visualization of the operating field. When compared to other medical imaging modalities, FGS is cheaper and superior in terms of resolution and number of molecules detectable.

Selected research

Market Outlook & Growth Opportunities

Global Fluorescence-Guided Surgery Systems Market Outlook and Growth Opportunities 2026

28 December 2025197 pages

Choose your research edition.

Industry ResearchFluorescence-Guided Surgery Systems Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Fluorescence-Guided Surgery Systems Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Fluorescence-Guided Surgery Systems Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Fluorescence-Guided Surgery Systems Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Fluorescence-Guided Surgery Systems Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

Fluorescence guided surgery (FGS), (also called 'Fluorescence image-guided surgery', or in the specific case of tumor resection, 'fluorescence guided resection') is a medical imaging technique used to detect fluorescently labelled structures during surgery. Similarly, to standard image-guided surgery, FGS has the purpose of guiding the surgical procedure and providing the surgeon of real time visualization of the operating field. When compared to other medical imaging modalities, FGS is cheaper and superior in terms of resolution and number of molecules detectable.

Global key players of Fluorescence-Guided Surgery Systems include Stryker, Hamamatsu Photonics, Medtronic, Quest Medical Imaging, Shimadzu and Fluoptics, etc. Top two players occupy for a share about 70%. North America is the largest market, with a share about 63%, followed by Europe and China. In terms of product, Only for Open Surgery is the largest segment, with a share over 86%. In terms of application, Cancer Surgeries is the largest market, with a share over 80%.

North America is the largest consumption place, with a consumption market share nearly 70% in 2019. Following North America, Europe is the second largest consumption place with 1/5 of the consumption market.

Read the full market overview

Market competition is intense. Stryker, Hamamatsu Photonics, Medtronic, Quest Medical Imaging, Shimadzu, Fluoptics, KARL STORZ, etc. are the leaders of the industry.

This report provides an overview of the global Fluorescence-Guided Surgery Systems market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Fluorescence-Guided Surgery Systems and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Fluorescence-Guided Surgery Systems sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Fluorescence-Guided Surgery Systems market size, projected growth trends, production technologies, key applications, and end-use industries.

Fluorescence-Guided Surgery Systems Segment by Company

Stryker

Hamamatsu Photonics

Medtronic

Quest Medical Imaging

Shimadzu

Fluoptics

KARL STORZ

Fluorescence-Guided Surgery Systems Segment by Type

Only for Open Surgery

System for Endoscopy

Fluorescence-Guided Surgery Systems Segment by Application

Cancer Surgeries

Cardiovascular Surgeries

Others

Fluorescence-Guided Surgery Systems Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Fluorescence-Guided Surgery Systems status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Fluorescence-Guided Surgery Systems market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Fluorescence-Guided Surgery Systems significant trends, drivers, influence factors in global and regions.

6. To analyze Fluorescence-Guided Surgery Systems competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Fluorescence-Guided Surgery Systems market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Fluorescence-Guided Surgery Systems and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Fluorescence-Guided Surgery Systems.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Fluorescence-Guided Surgery Systems market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Fluorescence-Guided Surgery Systems industry.

Chapter 3: Detailed analysis of Fluorescence-Guided Surgery Systems manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Fluorescence-Guided Surgery Systems in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Fluorescence-Guided Surgery Systems in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Fluorescence-Guided Surgery Systems Industry Trends Table 2. Fluorescence-Guided Surgery Systems Industry Drivers Table 3. Fluorescence-Guided Surgery Systems Industry Opportunities and Challenges Table 4. Fluorescence-Guided Surgery Systems Industry Restraints Table 5. Global Fluorescence-Guided Surgery Systems Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Fluorescence-Guided Surgery Systems Revenue Share by Company (2021-2026) Table 7. Global Fluorescence-Guided Surgery Systems Sales Volume by Company (Units) & (2021-2026) Table 8. Global Fluorescence-Guided Surgery Systems Sales Volume Share by Company (2021-2026) Table 9. Global Fluorescence-Guided Surgery Systems Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Fluorescence-Guided Surgery Systems Company Ranking, (2024-2026) & (USD Million) Table 11. Global Fluorescence-Guided Surgery Systems Key Company Manufacturing Base & Headquarters Table 12. Global Fluorescence-Guided Surgery Systems Company, Product Type & Application Table 13. Global Fluorescence-Guided Surgery Systems Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Fluorescence-Guided Surgery Systems by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Only for Open Surgery Table 18. Significant Companies of System for Endoscopy Table 19. Global Fluorescence-Guided Surgery Systems Sales Volume by Type 2021 VS 2025 VS 2032 (Units) Table 20. Global Fluorescence-Guided Surgery Systems Sales Volume by Type (2021-2026) & (Units) Table 21. Global Fluorescence-Guided Surgery Systems Sales Volume by Type (2027-2032) & (Units) Table 22. Global Fluorescence-Guided Surgery Systems Sales Volume Share by Type (2021-2026) Table 23. Global Fluorescence-Guided Surgery Systems Sales Volume Share by Type (2027-2032) Table 24. Global Fluorescence-Guided Surgery Systems Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Fluorescence-Guided Surgery Systems Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Fluorescence-Guided Surgery Systems Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Fluorescence-Guided Surgery Systems Sales Value Share by Type (2021-2026) Table 28. Global Fluorescence-Guided Surgery Systems Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Cancer Surgeries Table 30. Significant Companies of Cardiovascular Surgeries Table 31. Significant Companies of Others Table 32. Global Fluorescence-Guided Surgery Systems Sales Volume by Application 2021 VS 2025 VS 2032 (Units) Table 33. Global Fluorescence-Guided Surgery Systems Sales Volume by Application (2021-2026) & (Units) Table 34. Global Fluorescence-Guided Surgery Systems Sales Volume by Application (2027-2032) & (Units) Table 35. Global Fluorescence-Guided Surgery Systems Sales Volume Share by Application (2021-2026) Table 36. Global Fluorescence-Guided Surgery Systems Sales Volume Share by Application (2027-2032) Table 37. Global Fluorescence-Guided Surgery Systems Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Fluorescence-Guided Surgery Systems Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Fluorescence-Guided Surgery Systems Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Fluorescence-Guided Surgery Systems Sales Value Share by Application (2021-2026) Table 41. Global Fluorescence-Guided Surgery Systems Sales Value Share by Application (2027-2032) Table 42. Global Fluorescence-Guided Surgery Systems Sales by Region: 2021 VS 2025 VS 2032 (Units) Table 43. Global Fluorescence-Guided Surgery Systems Sales by Region (2021-2026) & (Units) Table 44. Global Fluorescence-Guided Surgery Systems Sales Market Share by Region (2021-2026) Table 45. Global Fluorescence-Guided Surgery Systems Sales by Region (2027-2032) & (Units) Table 46. Global Fluorescence-Guided Surgery Systems Sales Market Share by Region (2027-2032) Table 47. Global Fluorescence-Guided Surgery Systems Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Fluorescence-Guided Surgery Systems Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Fluorescence-Guided Surgery Systems Sales Value Share by Region (2021-2026) Table 50. Global Fluorescence-Guided Surgery Systems Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Fluorescence-Guided Surgery Systems Sales Value Share by Region (2027-2032) Table 52. Global Fluorescence-Guided Surgery Systems Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Fluorescence-Guided Surgery Systems Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Fluorescence-Guided Surgery Systems Sales by Country: 2021 VS 2025 VS 2032 (Units) Table 55. Global Fluorescence-Guided Surgery Systems Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Fluorescence-Guided Surgery Systems Sales by Country (2021-2026) & (Units) Table 57. Global Fluorescence-Guided Surgery Systems Sales Market Share by Country (2021-2026) Table 58. Global Fluorescence-Guided Surgery Systems Sales by Country (2027-2032) & (Units) Table 59. Global Fluorescence-Guided Surgery Systems Sales Market Share by Country (2027-2032) Table 60. Global Fluorescence-Guided Surgery Systems Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Fluorescence-Guided Surgery Systems Sales Value Market Share by Country (2021-2026) Table 62. Global Fluorescence-Guided Surgery Systems Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Fluorescence-Guided Surgery Systems Sales Value Market Share by Country (2027-2032) Table 64. Stryker Company Information Table 65. Stryker Business Overview Table 66. Stryker Fluorescence-Guided Surgery Systems Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Stryker Fluorescence-Guided Surgery Systems Product Portfolio Table 68. Stryker Recent Development Table 69. Hamamatsu Photonics Company Information Table 70. Hamamatsu Photonics Business Overview Table 71. Hamamatsu Photonics Fluorescence-Guided Surgery Systems Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Hamamatsu Photonics Fluorescence-Guided Surgery Systems Product Portfolio Table 73. Hamamatsu Photonics Recent Development Table 74. Medtronic Company Information Table 75. Medtronic Business Overview Table 76. Medtronic Fluorescence-Guided Surgery Systems Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Medtronic Fluorescence-Guided Surgery Systems Product Portfolio Table 78. Medtronic Recent Development Table 79. Quest Medical Imaging Company Information Table 80. Quest Medical Imaging Business Overview Table 81. Quest Medical Imaging Fluorescence-Guided Surgery Systems Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Quest Medical Imaging Fluorescence-Guided Surgery Systems Product Portfolio Table 83. Quest Medical Imaging Recent Development Table 84. Shimadzu Company Information Table 85. Shimadzu Business Overview Table 86. Shimadzu Fluorescence-Guided Surgery Systems Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Shimadzu Fluorescence-Guided Surgery Systems Product Portfolio Table 88. Shimadzu Recent Development Table 89. Fluoptics Company Information Table 90. Fluoptics Business Overview Table 91. Fluoptics Fluorescence-Guided Surgery Systems Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Fluoptics Fluorescence-Guided Surgery Systems Product Portfolio Table 93. Fluoptics Recent Development Table 94. KARL STORZ Company Information Table 95. KARL STORZ Business Overview Table 96. KARL STORZ Fluorescence-Guided Surgery Systems Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. KARL STORZ Fluorescence-Guided Surgery Systems Product Portfolio Table 98. KARL STORZ Recent Development Table 99. Key Raw Materials Table 100. Raw Materials Key Suppliers Table 101. Fluorescence-Guided Surgery Systems Distributors List Table 102. Fluorescence-Guided Surgery Systems Customers List Table 103. Research Programs/Design for This Report Table 104. Authors List of This Report Table 105. Secondary Sources Table 106. Primary Sources List of Figures Figure 1. Fluorescence-Guided Surgery Systems Product Image Figure 2. Global Fluorescence-Guided Surgery Systems Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Fluorescence-Guided Surgery Systems Sales Value (2021-2032) & (US$ Million) Figure 4. Global Fluorescence-Guided Surgery Systems Sales (2021-2032) & (Units) Figure 5. Global Fluorescence-Guided Surgery Systems Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Fluorescence-Guided Surgery Systems Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Only for Open Surgery Image Figure 10. System for Endoscopy Image Figure 11. Global Fluorescence-Guided Surgery Systems Sales Volume by Type (2021 VS 2025 VS 2032) & (Units) Figure 12. Global Fluorescence-Guided Surgery Systems Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Fluorescence-Guided Surgery Systems Sales Volume Share by Type (2021-2032) Figure 14. Global Fluorescence-Guided Surgery Systems Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Fluorescence-Guided Surgery Systems Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Fluorescence-Guided Surgery Systems Sales Value Share by Type (2021-2032) Figure 17. Cancer Surgeries Image Figure 18. Cardiovascular Surgeries Image Figure 19. Others Image Figure 20. Global Fluorescence-Guided Surgery Systems Sales Volume by Application (2021 VS 2025 VS 2032) & (Units) Figure 21. Global Fluorescence-Guided Surgery Systems Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Fluorescence-Guided Surgery Systems Sales Volume Share by Application (2021-2032) Figure 23. Global Fluorescence-Guided Surgery Systems Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Fluorescence-Guided Surgery Systems Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Fluorescence-Guided Surgery Systems Sales Value Share by Application (2021-2032) Figure 26. Global Fluorescence-Guided Surgery Systems Sales by Region: 2021 VS 2025 VS 2032 (Units) Figure 27. Global Fluorescence-Guided Surgery Systems Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Fluorescence-Guided Surgery Systems Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Fluorescence-Guided Surgery Systems Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Fluorescence-Guided Surgery Systems Sales Value (2021-2032) & (US$ Million) Figure 31. North America Fluorescence-Guided Surgery Systems Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Fluorescence-Guided Surgery Systems Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Fluorescence-Guided Surgery Systems Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Fluorescence-Guided Surgery Systems Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Fluorescence-Guided Surgery Systems Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Fluorescence-Guided Surgery Systems Sales Value (2021-2032) & (US$ Million) Figure 37. South America Fluorescence-Guided Surgery Systems Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Fluorescence-Guided Surgery Systems Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Fluorescence-Guided Surgery Systems Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Fluorescence-Guided Surgery Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Fluorescence-Guided Surgery Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Fluorescence-Guided Surgery Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Fluorescence-Guided Surgery Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Fluorescence-Guided Surgery Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Fluorescence-Guided Surgery Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Fluorescence-Guided Surgery Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Fluorescence-Guided Surgery Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Fluorescence-Guided Surgery Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Fluorescence-Guided Surgery Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Fluorescence-Guided Surgery Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Fluorescence-Guided Surgery Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Fluorescence-Guided Surgery Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Fluorescence-Guided Surgery Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Fluorescence-Guided Surgery Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Fluorescence-Guided Surgery Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Fluorescence-Guided Surgery Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Fluorescence-Guided Surgery Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Fluorescence-Guided Surgery Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Fluorescence-Guided Surgery Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Fluorescence-Guided Surgery Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Fluorescence-Guided Surgery Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Fluorescence-Guided Surgery Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Fluorescence-Guided Surgery Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Fluorescence-Guided Surgery Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Fluorescence-Guided Surgery Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Fluorescence-Guided Surgery Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Fluorescence-Guided Surgery Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Fluorescence-Guided Surgery Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Fluorescence-Guided Surgery Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Fluorescence-Guided Surgery Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Fluorescence-Guided Surgery Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Fluorescence-Guided Surgery Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Fluorescence-Guided Surgery Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Fluorescence-Guided Surgery Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Fluorescence-Guided Surgery Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Fluorescence-Guided Surgery Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Fluorescence-Guided Surgery Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Fluorescence-Guided Surgery Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Fluorescence-Guided Surgery Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Fluorescence-Guided Surgery Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Fluorescence-Guided Surgery Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Fluorescence-Guided Surgery Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Fluorescence-Guided Surgery Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Fluorescence-Guided Surgery Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Fluorescence-Guided Surgery Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Fluorescence-Guided Surgery Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Fluorescence-Guided Surgery Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Fluorescence-Guided Surgery Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Fluorescence-Guided Surgery Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Fluorescence-Guided Surgery Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Fluorescence-Guided Surgery Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Fluorescence-Guided Surgery Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Fluorescence-Guided Surgery Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Fluorescence-Guided Surgery Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Fluorescence-Guided Surgery Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Fluorescence-Guided Surgery Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Fluorescence-Guided Surgery Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Fluorescence-Guided Surgery Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Fluorescence-Guided Surgery Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Fluorescence-Guided Surgery Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Fluorescence-Guided Surgery Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Fluorescence-Guided Surgery Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Fluorescence-Guided Surgery Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Fluorescence-Guided Surgery Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Fluorescence-Guided Surgery Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Fluorescence-Guided Surgery Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Fluorescence-Guided Surgery Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Fluorescence-Guided Surgery Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Fluorescence-Guided Surgery Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Fluorescence-Guided Surgery Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Fluorescence-Guided Surgery Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Fluorescence-Guided Surgery Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Fluorescence-Guided Surgery Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Fluorescence-Guided Surgery Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Fluorescence-Guided Surgery Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Fluorescence-Guided Surgery Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Fluorescence-Guided Surgery Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Fluorescence-Guided Surgery Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Fluorescence-Guided Surgery Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Fluorescence-Guided Surgery Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Fluorescence-Guided Surgery Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Fluorescence-Guided Surgery Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Fluorescence-Guided Surgery Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Fluorescence-Guided Surgery Systems Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Fluorescence-Guided Surgery Systems Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Only for Open Surgery
  • System for Endoscopy
Applications
  • Cancer Surgeries
  • Cardiovascular Surgeries
  • Others
Companies covered
  • Stryker
  • Hamamatsu Photonics
  • Medtronic
  • Quest Medical Imaging
  • Shimadzu
  • Fluoptics
  • KARL STORZ

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Fluorescence-Guided Surgery Systems Sales Value (2021-2032)
  4. 1.2.2 Global Fluorescence-Guided Surgery Systems Sales Volume (2021-2032)
  5. 1.2.3 Global Fluorescence-Guided Surgery Systems Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Fluorescence-Guided Surgery Systems Market Dynamics
  1. 2.1 Fluorescence-Guided Surgery Systems Industry Trends
  2. 2.2 Fluorescence-Guided Surgery Systems Industry Drivers
  3. 2.3 Fluorescence-Guided Surgery Systems Industry Opportunities and Challenges
  4. 2.4 Fluorescence-Guided Surgery Systems Industry Restraints
3 Fluorescence-Guided Surgery Systems Market by Company
  1. 3.1 Global Fluorescence-Guided Surgery Systems Company Revenue Ranking in 2025
  2. 3.2 Global Fluorescence-Guided Surgery Systems Revenue by Company (2021-2026)
  3. 3.3 Global Fluorescence-Guided Surgery Systems Sales Volume by Company (2021-2026)
  4. 3.4 Global Fluorescence-Guided Surgery Systems Average Price by Company (2021-2026)
  5. 3.5 Global Fluorescence-Guided Surgery Systems Company Ranking (2024-2026)
  6. 3.6 Global Fluorescence-Guided Surgery Systems Company Manufacturing Base and Headquarters
  7. 3.7 Global Fluorescence-Guided Surgery Systems Company Product Type and Application
  8. 3.8 Global Fluorescence-Guided Surgery Systems Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Fluorescence-Guided Surgery Systems Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Fluorescence-Guided Surgery Systems Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Fluorescence-Guided Surgery Systems Market by Type
  1. 4.1 Fluorescence-Guided Surgery Systems Type Introduction
  2. 4.1.1 Only for Open Surgery
  3. 4.1.2 System for Endoscopy
  4. 4.2 Global Fluorescence-Guided Surgery Systems Sales Volume by Type
  5. 4.2.1 Global Fluorescence-Guided Surgery Systems Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Fluorescence-Guided Surgery Systems Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Fluorescence-Guided Surgery Systems Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Fluorescence-Guided Surgery Systems Sales Value by Type
  9. 4.3.1 Global Fluorescence-Guided Surgery Systems Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Fluorescence-Guided Surgery Systems Sales Value by Type (2021-2032)
  11. 4.3.3 Global Fluorescence-Guided Surgery Systems Sales Value Share by Type (2021-2032)
5 Fluorescence-Guided Surgery Systems Market by Application
  1. 5.1 Fluorescence-Guided Surgery Systems Application Introduction
  2. 5.1.1 Cancer Surgeries
  3. 5.1.2 Cardiovascular Surgeries
  4. 5.1.3 Others
  5. 5.2 Global Fluorescence-Guided Surgery Systems Sales Volume by Application
  6. 5.2.1 Global Fluorescence-Guided Surgery Systems Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Fluorescence-Guided Surgery Systems Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Fluorescence-Guided Surgery Systems Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Fluorescence-Guided Surgery Systems Sales Value by Application
  10. 5.3.1 Global Fluorescence-Guided Surgery Systems Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Fluorescence-Guided Surgery Systems Sales Value by Application (2021-2032)
  12. 5.3.3 Global Fluorescence-Guided Surgery Systems Sales Value Share by Application (2021-2032)
6 Fluorescence-Guided Surgery Systems Regional Sales and Value Analysis
  1. 6.1 Global Fluorescence-Guided Surgery Systems Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Fluorescence-Guided Surgery Systems Sales by Region (2021-2032)
  3. 6.2.1 Global Fluorescence-Guided Surgery Systems Sales by Region: 2021-2026
  4. 6.2.2 Global Fluorescence-Guided Surgery Systems Sales by Region (2027-2032)
  5. 6.3 Global Fluorescence-Guided Surgery Systems Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Fluorescence-Guided Surgery Systems Sales Value by Region (2021-2032)
  7. 6.4.1 Global Fluorescence-Guided Surgery Systems Sales Value by Region: 2021-2026
  8. 6.4.2 Global Fluorescence-Guided Surgery Systems Sales Value by Region (2027-2032)
  9. 6.5 Global Fluorescence-Guided Surgery Systems Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Fluorescence-Guided Surgery Systems Sales Value (2021-2032)
  12. 6.6.2 North America Fluorescence-Guided Surgery Systems Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Fluorescence-Guided Surgery Systems Sales Value (2021-2032)
  15. 6.7.2 Europe Fluorescence-Guided Surgery Systems Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Fluorescence-Guided Surgery Systems Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Fluorescence-Guided Surgery Systems Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Fluorescence-Guided Surgery Systems Sales Value (2021-2032)
  21. 6.9.2 South America Fluorescence-Guided Surgery Systems Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Fluorescence-Guided Surgery Systems Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Fluorescence-Guided Surgery Systems Sales Value Share by Country, 2025 VS 2032
7 Fluorescence-Guided Surgery Systems Country-level Sales and Value Analysis
  1. 7.1 Global Fluorescence-Guided Surgery Systems Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Fluorescence-Guided Surgery Systems Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Fluorescence-Guided Surgery Systems Sales by Country (2021-2032)
  4. 7.3.1 Global Fluorescence-Guided Surgery Systems Sales by Country (2021-2026)
  5. 7.3.2 Global Fluorescence-Guided Surgery Systems Sales by Country (2027-2032)
  6. 7.4 Global Fluorescence-Guided Surgery Systems Sales Value by Country (2021-2032)
  7. 7.4.1 Global Fluorescence-Guided Surgery Systems Sales Value by Country (2021-2026)
  8. 7.4.2 Global Fluorescence-Guided Surgery Systems Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Fluorescence-Guided Surgery Systems Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Fluorescence-Guided Surgery Systems Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Fluorescence-Guided Surgery Systems Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Fluorescence-Guided Surgery Systems Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Fluorescence-Guided Surgery Systems Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Fluorescence-Guided Surgery Systems Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Fluorescence-Guided Surgery Systems Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Fluorescence-Guided Surgery Systems Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Fluorescence-Guided Surgery Systems Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Fluorescence-Guided Surgery Systems Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Fluorescence-Guided Surgery Systems Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Fluorescence-Guided Surgery Systems Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Fluorescence-Guided Surgery Systems Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Fluorescence-Guided Surgery Systems Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Fluorescence-Guided Surgery Systems Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Fluorescence-Guided Surgery Systems Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Fluorescence-Guided Surgery Systems Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Fluorescence-Guided Surgery Systems Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Fluorescence-Guided Surgery Systems Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Fluorescence-Guided Surgery Systems Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Fluorescence-Guided Surgery Systems Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Fluorescence-Guided Surgery Systems Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Fluorescence-Guided Surgery Systems Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Fluorescence-Guided Surgery Systems Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Fluorescence-Guided Surgery Systems Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Fluorescence-Guided Surgery Systems Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Fluorescence-Guided Surgery Systems Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Fluorescence-Guided Surgery Systems Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Fluorescence-Guided Surgery Systems Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Fluorescence-Guided Surgery Systems Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Fluorescence-Guided Surgery Systems Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Fluorescence-Guided Surgery Systems Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Fluorescence-Guided Surgery Systems Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Fluorescence-Guided Surgery Systems Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Fluorescence-Guided Surgery Systems Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Fluorescence-Guided Surgery Systems Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Fluorescence-Guided Surgery Systems Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Fluorescence-Guided Surgery Systems Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Fluorescence-Guided Surgery Systems Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Fluorescence-Guided Surgery Systems Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Fluorescence-Guided Surgery Systems Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Fluorescence-Guided Surgery Systems Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Fluorescence-Guided Surgery Systems Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Fluorescence-Guided Surgery Systems Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Fluorescence-Guided Surgery Systems Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Fluorescence-Guided Surgery Systems Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Fluorescence-Guided Surgery Systems Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Fluorescence-Guided Surgery Systems Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Fluorescence-Guided Surgery Systems Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Fluorescence-Guided Surgery Systems Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Fluorescence-Guided Surgery Systems Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Fluorescence-Guided Surgery Systems Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Fluorescence-Guided Surgery Systems Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Fluorescence-Guided Surgery Systems Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Fluorescence-Guided Surgery Systems Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Fluorescence-Guided Surgery Systems Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Fluorescence-Guided Surgery Systems Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Fluorescence-Guided Surgery Systems Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Fluorescence-Guided Surgery Systems Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Fluorescence-Guided Surgery Systems Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Fluorescence-Guided Surgery Systems Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Fluorescence-Guided Surgery Systems Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Fluorescence-Guided Surgery Systems Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Fluorescence-Guided Surgery Systems Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Fluorescence-Guided Surgery Systems Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Fluorescence-Guided Surgery Systems Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Fluorescence-Guided Surgery Systems Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Fluorescence-Guided Surgery Systems Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Fluorescence-Guided Surgery Systems Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Fluorescence-Guided Surgery Systems Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Fluorescence-Guided Surgery Systems Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Fluorescence-Guided Surgery Systems Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Fluorescence-Guided Surgery Systems Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Fluorescence-Guided Surgery Systems Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Fluorescence-Guided Surgery Systems Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Fluorescence-Guided Surgery Systems Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Fluorescence-Guided Surgery Systems Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Fluorescence-Guided Surgery Systems Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Fluorescence-Guided Surgery Systems Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Fluorescence-Guided Surgery Systems Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Fluorescence-Guided Surgery Systems Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Fluorescence-Guided Surgery Systems Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Fluorescence-Guided Surgery Systems Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Fluorescence-Guided Surgery Systems Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Stryker
  2. 8.1.1 Stryker Company Information
  3. 8.1.2 Stryker Business Overview
  4. 8.1.3 Stryker Fluorescence-Guided Surgery Systems Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Stryker Fluorescence-Guided Surgery Systems Product Portfolio
  6. 8.1.5 Stryker Recent Developments
  7. 8.2 Hamamatsu Photonics
  8. 8.2.1 Hamamatsu Photonics Company Information
  9. 8.2.2 Hamamatsu Photonics Business Overview
  10. 8.2.3 Hamamatsu Photonics Fluorescence-Guided Surgery Systems Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Hamamatsu Photonics Fluorescence-Guided Surgery Systems Product Portfolio
  12. 8.2.5 Hamamatsu Photonics Recent Developments
  13. 8.3 Medtronic
  14. 8.3.1 Medtronic Company Information
  15. 8.3.2 Medtronic Business Overview
  16. 8.3.3 Medtronic Fluorescence-Guided Surgery Systems Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Medtronic Fluorescence-Guided Surgery Systems Product Portfolio
  18. 8.3.5 Medtronic Recent Developments
  19. 8.4 Quest Medical Imaging
  20. 8.4.1 Quest Medical Imaging Company Information
  21. 8.4.2 Quest Medical Imaging Business Overview
  22. 8.4.3 Quest Medical Imaging Fluorescence-Guided Surgery Systems Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Quest Medical Imaging Fluorescence-Guided Surgery Systems Product Portfolio
  24. 8.4.5 Quest Medical Imaging Recent Developments
  25. 8.5 Shimadzu
  26. 8.5.1 Shimadzu Company Information
  27. 8.5.2 Shimadzu Business Overview
  28. 8.5.3 Shimadzu Fluorescence-Guided Surgery Systems Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Shimadzu Fluorescence-Guided Surgery Systems Product Portfolio
  30. 8.5.5 Shimadzu Recent Developments
  31. 8.6 Fluoptics
  32. 8.6.1 Fluoptics Company Information
  33. 8.6.2 Fluoptics Business Overview
  34. 8.6.3 Fluoptics Fluorescence-Guided Surgery Systems Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Fluoptics Fluorescence-Guided Surgery Systems Product Portfolio
  36. 8.6.5 Fluoptics Recent Developments
  37. 8.7 KARL STORZ
  38. 8.7.1 KARL STORZ Company Information
  39. 8.7.2 KARL STORZ Business Overview
  40. 8.7.3 KARL STORZ Fluorescence-Guided Surgery Systems Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 KARL STORZ Fluorescence-Guided Surgery Systems Product Portfolio
  42. 8.7.5 KARL STORZ Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Fluorescence-Guided Surgery Systems Value Chain Analysis
  2. 9.1.1 Fluorescence-Guided Surgery Systems Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Fluorescence-Guided Surgery Systems Sales Mode & Process
  6. 9.2 Fluorescence-Guided Surgery Systems Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Fluorescence-Guided Surgery Systems Distributors
  9. 9.2.3 Fluorescence-Guided Surgery Systems Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst